Emile Voest Group

Emile Voest

Oncode Investigator at NKI

My Research

Emile Voest is medical director of the Netherlands Cancer Institute, senior scientist of the Oncode Institute, medical oncologist and translational scientist. In addition to his clinical and managerial responsibilities he is leading his own research group. His laboratory group is devoted to bringing personalized medicine to patients and is focused on mechanistic studies and identification of biomarkers that predict treatment efficacy. The results from these studies are subsequently translated in clinical studies. These translational approaches are performed across tumor types with emphasis on epithelial tumors.

His research is in the area of personalized medicine consists of large scale genomic sequencing of patients with metastatic cancer, the development of primary cultures of tumors for ex vivo testing (including tumor organoids) and the use of these cultures to improve drug development and to determine which treatment is best for a specific patient.

Key Publications

  1. D.L. van der Velden, H. van der Wijngaart, L.R. Hoes, J.M. van Berge Henegouwen, E. van Werkhoven, P. Roepman, R.L. Schilsky, W.W.J. de Leng, A.D.R. Huitema, B. Nuijen, P.M. Nederlof, C.M.L. van Herpen, D.J.A. de Groot, L.A. Devriese, A. Hoeben, M.J.A. de Jonge, M. Chalabi, E.F. Smit, A.J. de Langen, N. Mehra, M. Labots, E. Kapiteijn, S. Sleijfer, E. Cuppen , H.M.W. Verheul, H. Gelderblom, E.E. Voest. Drug rediscovery protocol: expanded use of existing anti-cancer drugs. Nature, 2019 574(7776):127-131
  2. Salo N. Ooft, Fleur Weeber, Krijn K. Dijkstra, Chelsea M. McLean, Sovann Kaing, Erik van Werkhoven, Louisa Hoes, Daniel Vis, Joris van de Haar, Luuk Schipper, Warner Prevoo, Petur Snaebjornsson, Daphne van der Velden, Myriam Chalabi, Henk Boot, Monique van Leerdam, Haiko J. Bloemendal, Laurens V. Beerepoot, Lodewyk Wessels, Edwin Cuppen, Hans Clevers and Emile. E. Voest. Patient-derived organoids predict response to chemotherapy in metastatic colorectal cancer patients. Sci Transl Med. 2019 Oct 9;11(513)
  3. Peter Priestley, Jonathan Baber, Martijn P. Lolkema, Neeltje Steeghs, Ewart de Bruijn, Korneel Duyvesteyn, Susan Haidari, Arne van Hoeck, Wendy Onstenk, Paul Roepman, Charles Shale, Mircea Voda, Haiko J. Bloemendal, Vivianne C.G. Tjan-Heijnen, Carla M.L. van Herpen, Mariette Labots, Petronella O. Witteveen, Egbert F. Smit, Stefan Sleijfer, Emile E. Voest, Edwin Cuppen. Pan-cancer whole genome analyses of metastatic solid tumors. Nature,575(7781):210-216]
  4. van de Haar, J., Canisius, S., Yu, M.K., Voest, E.E., Wessels, L.F.A., Ideker, T. Identifying epistasis in cancer genomes: a delicate affair. Cell, 2019; 177(6):1375-1383
  5. Krijn K. Dijkstra, Chiara M. Cattaneo, Fleur Weeber, Myriam Chalabi, Joris van de Haar, Lorenzo Fanchi, Maarten Slagter, Daphne L. van der Velden, Sovann Kaing, Sander Kelderman, Nienke van Rooij, Monique E. van Leerdam, Annekatrien Depla, Egbert Smit, Koen Hartemink, Rosa Groot, Monika Wolkers, Norman Sachs, Petur Snaebjornsson, Kim Monkhorst, John Haanen, Hans Clevers, Ton N. Schumacher, Emile E. Voest. Facilitating individualized T cell therapy by co-culture of peripheral blood lymphocytes and tumor organoids. Cell 2018, 174(6):1586-1598
Contact Information
Emile Voest Oncode Investigator

More Research

Research Strategy
Focus and Approach
Over 800 scientists working under a single strategy. Oncode is all about uniting efforts and bringing focus to research.
Support Programme
Our supporting programmes
New plans that help fulfil Oncode's objectives get our full support. Young talents are matched with mentors on the basis of their personal endeavours.
Research Groups
Our Groups
We firmly believe in sharing knowledge. From experienced veterans to talented young researchers, we work together in 61 groups.